Marker Therapeutics Inc (MRKR)

[Dodger1]

Yeah...I think Glen was pretty upbeat and I got the impression with the up coming news or milestones, the stock will go up.

Sugarshaker wrote:

"Anticipated 2017 Milestones:

2Q 2017: On track to achieve 50% enrollment in ongoing Phase 2 dosing study of TPIV 200 for treating triple-negative breast cancer (TNBC)
3Q 2017: Publish long-term safety, immune response and survival data from completed Phase 1 clinical study of TPIV 200
3Q 2017: Report interim results from ongoing Phase 2 study of TPIV 200 in combination with AstraZeneca's durvalumab in patients with platinum-resistant ovarian cancer
3Q 2017: Mayo Clinic to initiate 280-patient Phase 2 study of TPIV 200 in women
with advanced triple-negative breast cancer
4Q 2017: On track to complete enrollment in Phase 2 dosing study of TPIV 200 in TNBC
Year end 2017: File amended investigational new drug application (IND) for TPIV 110 for treating HER2/neu+ breast cancer.

My wish is Glynn will make these milestones happen."

Thank you Sugarshaker for that. I would like to add the following:

www.youtube.com/watch?v=DsyZTfKUP8o